More specifically, in treatment-naïve ES-SCLC patients the percentage of CD3+CD8+PD-1+ T-cells was correlated positively with CTCs expressing PD-L1 in circulation, which is probably linked to the eventual immune evasion of tumor cells. The gene discussed is CD8A; the disease is neoplasm.